Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/14/2003EP1309616A1 Integrin binding motif containing peptides and methods of treating skeletal diseases
05/14/2003EP1309553A1 New aporphine esters and their use in therapy
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309369A1 Electro-powder
05/14/2003EP1309365A2 Constant rate fluid delivery device with selectable flow rate and titratable bolus button
05/14/2003EP1309353A2 Flavone-containing plant extract solutions having improved storage and heat stability
05/14/2003EP1309352A1 Antifungal ketoconazole composition for topical use
05/14/2003EP1309351A1 Dermatological formulation
05/14/2003EP1309344A1 Oral solid dose vaccine
05/14/2003EP1309332A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections
05/14/2003EP1309331A2 Medicine for fighting against sexual dysfunction
05/14/2003EP1309327A2 Pharmaceutical compositions of estrogenic agents
05/14/2003EP1309319A2 Pharmaceutical, effervescent formulation containing ramipril
05/14/2003EP1309318A1 Consumable container
05/14/2003EP1309317A1 Pharmaceutical compositions comprising amlodipine maleate
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1309314A2 Method of making tablets and tablet compositions produced therefrom
05/14/2003EP1309313A1 Composite material and process for increasing bioavailability and activity of a beneficial agent
05/14/2003EP1309312A2 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
05/14/2003EP1309301A1 Medicated wrap
05/14/2003EP1309279A1 Sutures and coatings made from therapeutic absorbable glass
05/14/2003EP1192170B1 Propargyl phenyl ether a2a receptor agonists
05/14/2003EP1189595B1 Ophthalmic compositions in form of aqueous gels
05/14/2003EP1137399B1 Improvements in or relating to powders
05/14/2003EP1051194B1 Process for making absorbable microparticles
05/14/2003EP1041996A4 Keratinocyte growth factor-2 formulations
05/14/2003EP0975337B1 Fast release compressed tablet of flurbiprofen
05/14/2003EP0819006B1 Preparation of sodium chloride aerosol formulations
05/14/2003EP0817617B1 Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
05/14/2003EP0800383B1 Pharmaceutical compositions comprising proliposome powders for inhalation
05/14/2003EP0794783B1 Cyclodextrins as suspending agents for pharmaceutical suspensions
05/14/2003EP0749308B1 Film coated tablet of paracetamol and domperidone
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418113A medicinal aerosol formulation
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1418104A Cosmetic use of hop and ornithine
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1418097A Oxazolidinone toble formulation
05/14/2003CN1418093A ultraviolet shielding adhesive preparation
05/14/2003CN1418092A Stabilised oversaturated transdermal therapeutical matrix system
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1418090A Process for preparation of accelerated release formulations using compressed fluids
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1418081A Capsules
05/14/2003CN1418079A Container for linezolid intravenous solution
05/14/2003CN1418077A Methods and devices for preventing transmission of sexually transmitted diseases
05/14/2003CN1418062A Digestable chewing gum
05/14/2003CN1417326A Latent-energy regeneration cell
05/14/2003CN1416918A Medicine conveyance through conformal film
05/14/2003CN1416902A Combined polymer-medicine micelle and its prepn process
05/14/2003CN1416895A Slow releasing microballoon injection of fish mature accelerating hormone and its prepn
05/14/2003CN1416889A Eye ointment and its prepn
05/14/2003CN1416887A Ointment painted to nasal cavity for preventing cold and influenza and its prepn
05/14/2003CN1416885A Andrographis gel as supplementary medicine for treating preiodontitis
05/14/2003CN1416882A Burn treating Chinese medicine liquid and its prepn
05/14/2003CN1416847A Nanometer level American ginseng product and its production process
05/14/2003CN1416846A Nanometer level ginseng product and its production process
05/14/2003CN1416822A Nano freshwater mussel mineral Chinese medicine and its prepn process
05/14/2003CN1416821A Nanometer level pearl product and its prepn process
05/14/2003CN1416820A Nanometer level pilose antler and pilose antler product and their prepn process
05/14/2003CN1416814A Medicine prepn for injection and its prepn process
05/14/2003CN1416811A Indomethacin liposome eye drops
05/14/2003CN1416809A Aloe powder with high active matter content and its production process
05/14/2003CN1416808A Oral biological macromolecular medicine administrating system based on biological adhesive microballoon
05/14/2003CN1108183C Method for treating particulate material with coating substance and device for implementing such method
05/14/2003CN1108168C Chinese medicine preparation for treating angina pectoris and its dispensation process
05/14/2003CN1108164C Freshly squeezing and shadily drying process to prepare Chinese herbal medicine pieces
05/14/2003CN1108157C Gel composition for treating pulmonary tuberculosis cavity difficult to cure it
05/14/2003CN1108156C Long-acting analgesic used mainly for operational cut and traumatic wound
05/14/2003CN1108155C Preparation absorbed through skin, containing woluke kinds of medicine
05/14/2003CN1108153C Oral compositions containing ondansetron
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/14/2003CN1108150C Method and composition for increasing calcium uptake
05/14/2003CN1108149C Composition for forming solid particles
05/14/2003CN1108098C Gel formulation
05/13/2003US6564105 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
05/13/2003US6564092 Transdermal or transmucosal drug delivery device
05/13/2003US6562980 Method for producing 5-aryloxymethyl-2-oxazolidinones
05/13/2003US6562952 Precipitation of proteins from organic solutions
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562872 Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof
05/13/2003US6562868 Method of treating female sexual dysfunction, comprising administering to a human a therapeutically effective and physiologically acceptable amount of a prostaglandin selected from the group consisting of 19-hydroxy-PGE2,
05/13/2003US6562855 Comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist.
05/13/2003US6562835 One morphinan selected from the group consisting of dextromethorphan, dextrorphan and at least one active agent selected from tricyclic antidepressants, antispasmodics, direct-acting bladder smooth muscle relaxants, and estrogens
05/13/2003US6562826 To maintain human ranolazine plasma levels at therapeutic levels
05/13/2003US6562802 Anionic ethylene amine scavenger; and cationic, hydrophilic amine containing polymer like chitosan and derivatives, cationic polyethylenes, DEAE-4, and polyornithine
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562495 Nanoscale catalyst compositions from complex and non-stoichiometric compositions
05/13/2003US6562459 Method for the production of spherical microparticles consisting totally or partly of at least one water insoluble polyglucan containing branches and microparticles produced according to said method
05/13/2003US6562392 Hard caramel product
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562375 Stable pharmaceutical composition for oral use
05/13/2003US6562372 Tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
05/13/2003US6562371 Basic compound that becomes charged at physiological pH and lipid drug delivery system; blood stability
05/13/2003US6562370 A combination of an estrogen and progestin for female hormoe replacement therapy, to provide contraception; minimizes skin damage, irritation or sensitization
05/13/2003US6562369 Administering drug to localized region of human patient's body surface in combination with hydroxide releasing agent applied to body surface
1 ... 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 ... 2991